Global Recombinant Protein Expression System Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Recombinant Protein Expression System Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Proteins produced from such DNA templates are called recombinant proteins. Traditional strategies for recombinant protein expression involve transfecting cells with a DNA vector that contains the template and then culturing the cells so that they transcribe and translate the desired protein.
Recombinant Protein Expression System report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Protein Expression System market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmaceutical Companies and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Protein Expression System industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Recombinant Protein Expression System key companies include Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc. Thermo Fisher, Merck, GenScript are top 3 players and held % share in total in 2022.
Recombinant Protein Expression System can be divided into Mammalian Cell Expression System, Prokaryotic Expression System, Insect Cell Expression System and Yeast Expression System, etc. Mammalian Cell Expression System is the mainstream product in the market, accounting for % share globally in 2022.
Recombinant Protein Expression System is widely used in various fields, such as Pharmaceutical Companies, Research Institutes and Others,, etc. Pharmaceutical Companies provides greatest supports to the Recombinant Protein Expression System industry development. In 2022, global % share of Recombinant Protein Expression System went into Pharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Protein Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fisher
Merck
GenScript
Agilent
Takara Bio
Bio-Rad Laboratories
Qiagen N.V
Charles River
Sartorius
Corning
FUJIFILM Irvine Scientific
Lonza Group
Bioneer Corporation
Promega
Oxford Expression Technologies
ProteoGenix
Abeomics
New England Biolabs
Promab Biotechnologies
Sino Biological
Jena Bioscience
Lifesensors
Leading biology
Peak Proteins
Segment by Type
Mammalian Cell Expression System
Prokaryotic Expression System
Insect Cell Expression System
Yeast Expression System
Cell-free Expression System
Algal-based Expression System
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Protein Expression System market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Recombinant Protein Expression System introduction, etc. Recombinant Protein Expression System Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Recombinant Protein Expression System market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Recombinant Protein Expression System report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Recombinant Protein Expression System market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmaceutical Companies and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Recombinant Protein Expression System industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Recombinant Protein Expression System key companies include Thermo Fisher, Merck, GenScript, Agilent, Takara Bio, Bio-Rad Laboratories, Qiagen N.V, Charles River and Sartorius, etc. Thermo Fisher, Merck, GenScript are top 3 players and held % share in total in 2022.
Recombinant Protein Expression System can be divided into Mammalian Cell Expression System, Prokaryotic Expression System, Insect Cell Expression System and Yeast Expression System, etc. Mammalian Cell Expression System is the mainstream product in the market, accounting for % share globally in 2022.
Recombinant Protein Expression System is widely used in various fields, such as Pharmaceutical Companies, Research Institutes and Others,, etc. Pharmaceutical Companies provides greatest supports to the Recombinant Protein Expression System industry development. In 2022, global % share of Recombinant Protein Expression System went into Pharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Recombinant Protein Expression System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher
Merck
GenScript
Agilent
Takara Bio
Bio-Rad Laboratories
Qiagen N.V
Charles River
Sartorius
Corning
FUJIFILM Irvine Scientific
Lonza Group
Bioneer Corporation
Promega
Oxford Expression Technologies
ProteoGenix
Abeomics
New England Biolabs
Promab Biotechnologies
Sino Biological
Jena Bioscience
Lifesensors
Leading biology
Peak Proteins
Segment by Type
Mammalian Cell Expression System
Prokaryotic Expression System
Insect Cell Expression System
Yeast Expression System
Cell-free Expression System
Algal-based Expression System
Segment by Application
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Recombinant Protein Expression System market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Recombinant Protein Expression System introduction, etc. Recombinant Protein Expression System Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Recombinant Protein Expression System market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices